Skip to main content

Advertisement

SpringerLink
Log in

The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis

  • ORIGINAL ARTICLE
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

We constructed a mathematical model for assessing the cost-effectiveness of providing BMD (bone mineral density) scans to Japanese women aged 55 years and over and treating, with risedronate, those that are shown to be osteoporotic. Fracture rates, cost data, utility values, and the increased risks of fractures associated with T-score and vertebral fracture history were taken from published literature. We estimated the cost of fractures avoided due to risedronate treatment, allowing the net changes in cost, incorporating both intervention and fracture costs to be calculated. The QALYs (quality adjusted life years) gained through treatment were calculated enabling cost per QALY ratios to be presented. Further analyses were undertaken assuming treatment was reserved for older women and/or those who had sustained a vertebral fracture in the previous 2 years. Cost per QALY values were inversely related to absolute risk of fracture. Assuming a cost per QALY value threshold of US$100,000, we concluded that providing BMD scans to women aged 70 years and over who had sustained a vertebral fracture in the previous 2 years and treating those that were osteoporotic was cost-effective. However, providing BMD scans for women without a vertebral fracture in the previous 2 years was not cost-effective, even in women aged 85 years and older.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. H Kishimoto (2005) ArticleTitleChange in the definition of osteoporosis especially on bone quality Clin Calcium 15 736–740 Occurrence Handle15876733

    PubMed  Google Scholar 

  2. InstitutionalAuthorNameAnonymous (1997) ArticleTitleWho are candidates for prevention and treatment for osteoporosis? Osteoporos Int 7 1–6

    Google Scholar 

  3. InstitutionalAuthorNameAnonymous (1993) ArticleTitleConsensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis Am J Med 94 646–650 Occurrence Handle10.1016/0002-9343(93)90218-E

    Article  Google Scholar 

  4. JA Kanis (1994) ArticleTitleAssessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group Osteoporos Int 4 368–381 Occurrence Handle7696835 Occurrence Handle10.1007/BF01622200 Occurrence Handle1:STN:280:DyaK2M3htVyktA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. JA Kanis CC Gluer (2000) ArticleTitleAn update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation Osteoporos Int 11 192–202 Occurrence Handle10824234 Occurrence Handle10.1007/s001980050281 Occurrence Handle1:STN:280:DC%2BD3c3osVanug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  6. SC Schuit M van der Klift AE Weel CE de Laet H Burger E Seeman A Hofman AG Uitterlinden JP van Leeuwen HA Pols (2004) ArticleTitleFracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone (NY) 34 195–202 Occurrence Handle1:STN:280:DC%2BD2c%2FltVCjsg%3D%3D

    CAS  Google Scholar 

  7. H Orimo Y Hayashi M Fukunaga T Sone S Fujiwara M Shiraki K Kushida S Miyamoto S Soen J Nishimura Y Oh-Hashi T Hosoi I Gorai H Tanaka T Igai H Kishimoto (2001) ArticleTitleDiagnostic criteria for primary osteoporosis: year 2000 revision J Bone Miner Metab 19 331–337 Occurrence Handle11685647 Occurrence Handle10.1007/s007740170001 Occurrence Handle1:STN:280:DC%2BD3MngvFGntw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  8. NF Ray JK Chan M Thamer LJ Melton SuffixIII (1997) ArticleTitleMedical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation J Bone Miner Res 12 24–35 Occurrence Handle9240722 Occurrence Handle10.1359/jbmr.1997.12.1.24 Occurrence Handle1:STN:280:DyaK2szot1Oguw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  9. LJ Melton SuffixIII (1993) ArticleTitleHip fractures: a worldwide problem today and tomorrow Bone (NY) 14 IssueIDsuppl 1 S1–S8

    Google Scholar 

  10. Y Hayashi (2004) ArticleTitleHealth economics of treatment of osteoporosis (in Japanese) Geriatr Med 42 613–618

    Google Scholar 

  11. R Lindsay (1995) ArticleTitleThe burden of osteoporosis: cost Am J Med 98 9S–11S Occurrence Handle7709941 Occurrence Handle10.1016/S0002-9343(05)80038-5 Occurrence Handle1:STN:280:DyaK2M3isFaqug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  12. R Eastell IT Boyle J Compston C Cooper I Fogelman RM Francis DJ Hosking DW Purdie S Ralston J Reeve DM Reid RG Russell JC Stevenson (1998) ArticleTitleManagement of male osteoporosis: report of the UK Consensus Group Q J Med 91 71–92 Occurrence Handle1:STN:280:DyaK1c3ktVSguw%3D%3D

    CAS  Google Scholar 

  13. SR Cummings SM Rubin D Black (1990) ArticleTitleThe future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen Clin Orthop Relat Res 252 163–166 Occurrence Handle2302881

    PubMed  Google Scholar 

  14. http://www.nice.org.uk/pdf/TAP_Methods.pdf

  15. W Whang JE Sisk DF Heitjan AJ Moskowitz (1999) ArticleTitleProbabilistic sensitivity analysis in cost-effectiveness. An application from a study of vaccination against pneumococcal bacteremia in the elderly Int J Technol Assess Health Care 15 563–572 Occurrence Handle10874382 Occurrence Handle1:STN:280:DC%2BD3czjt1GmtA%3D%3D

    PubMed  CAS  Google Scholar 

  16. R Marcus M Wong H Heath SuffixIII JL Stock (2002) ArticleTitleAntiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint Endocr Rev 23 16–37 Occurrence Handle11844743 Occurrence Handle10.1210/er.23.1.16 Occurrence Handle1:CAS:528:DC%2BD38XitFOqu7k%3D

    Article  PubMed  CAS  Google Scholar 

  17. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut SuffixIII J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller (1999) ArticleTitleEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group JAMA 282 1344–1352 Occurrence Handle10527181 Occurrence Handle10.1001/jama.282.14.1344 Occurrence Handle1:CAS:528:DyaK1MXmvFansr0%3D

    Article  PubMed  CAS  Google Scholar 

  18. P Levy E Levy M Audran M Cohen-Solal P Fardellone JM Le Parc (2002) ArticleTitleThe cost of osteoporosis in men: the French situation Bone (NY) 30 631–636 Occurrence Handle1:STN:280:DC%2BD383gtFyitQ%3D%3D

    CAS  Google Scholar 

  19. J Krappweis A Rentsch UI Schwarz KJ Krobot W Kirch (1999) ArticleTitleOutpatient costs of osteoporosis in a national health insurance population Clin Ther 21 2001–2014 Occurrence Handle10890269 Occurrence Handle10.1016/S0149-2918(00)86745-4 Occurrence Handle1:STN:280:DC%2BD3czks1ehsQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  20. BC Martin MA Chisholm JA Kotzan (2001) ArticleTitleIsolating the cost of osteoporosis-related fracture for postmenopausal women. A population-based study Gerontology 47 21–29 Occurrence Handle11244288 Occurrence Handle10.1159/000052766 Occurrence Handle1:STN:280:DC%2BD3M3mvFGmug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  21. InstitutionalAuthorNameMHLW (2004) Patient Survey 2002 (in Japanese) Health and Welfare Statistics Association Tokyo 684

    Google Scholar 

  22. http://wwwdbtk.mhlw.go.jp/IPPAN/ippan/scm_k_Ichiran

  23. InstitutionalAuthorNameMHLW (2004) Patient Survey 2002 (in Japanese) Health and Welfare Statistics Association Tokyo 49

    Google Scholar 

  24. S Fujiwara F Kasagi N Masunari K Naito G Suzuki M Fukunaga (2003) ArticleTitleFracture prediction from bone mineral density in Japanese men and women J Bone Miner Res 18 1547–1553 Occurrence Handle12929946 Occurrence Handle10.1359/jbmr.2003.18.8.1547

    Article  PubMed  Google Scholar 

  25. K Kushida M Fukunaga H Kishimoto M Shiraki A Itabashi T Inoue K Kaneda H Morii H Nawata K Yamamoto Y Ohashi H Orimo (2004) ArticleTitleA comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate: a randomized, double-masked trial J Bone Miner Metab 22 469–478 Occurrence Handle15316868 Occurrence Handle1:CAS:528:DC%2BD2cXmslCit7g%3D

    PubMed  CAS  Google Scholar 

  26. M Shiraki M Fukunaga K Kushida H Kishimoto Y Taketani H Minaguchi T Inoue R Morita H Morii K Yamamoto Y Ohashi H Orimo (2003) ArticleTitleA double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group) Osteoporos Int 14 225–234 Occurrence Handle12730746 Occurrence Handle1:CAS:528:DC%2BD3sXlslOls7c%3D

    PubMed  CAS  Google Scholar 

  27. T Majima Y Komatsu K Doi C Takagi M Shigemoto A Fukao T Morimoto J Corners K Nakao (2006) ArticleTitleClinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease J Bone Miner Metab 24 105–113 Occurrence Handle16502116 Occurrence Handle10.1007/s00774-005-0655-y Occurrence Handle1:CAS:528:DC%2BD28XhvVWjsrc%3D

    Article  PubMed  CAS  Google Scholar 

  28. Y Sato J Iwamoto T Kanoko K Satoh (2005) ArticleTitleRisedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke Arch Intern Med 165 1743–1748 Occurrence Handle16087822 Occurrence Handle10.1001/archinte.165.15.1743 Occurrence Handle1:CAS:528:DC%2BD2MXpslGgs7Y%3D

    Article  PubMed  CAS  Google Scholar 

  29. J Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 83–91 Occurrence Handle10663363 Occurrence Handle10.1007/s001980050010 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsr0%3D

    Article  PubMed  CAS  Google Scholar 

  30. MR McClung P Geusens PD Miller H Zippel WG Bensen C Roux S Adami I Fogelman T Diamond R Eastell PJ Meunier JY Reginster (2001) ArticleTitleEffect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group N Engl J Med 344 333–340 Occurrence Handle11172164 Occurrence Handle10.1056/NEJM200102013440503 Occurrence Handle1:CAS:528:DC%2BD3MXht1Wlu7g%3D

    Article  PubMed  CAS  Google Scholar 

  31. InstitutionalAuthorNameInstitute SIR (2006) Remuneration Standard for Medical Services, version 4 Japan Social Insurance Research Institute Tokyo 162

    Google Scholar 

  32. InstitutionalAuthorNameJibou (2004) National Health Insurance Price List (in Japanese) Jibou Press Tokyo

    Google Scholar 

  33. Stevenson MD, Davis S (2005) Analyses of the cost-effectiveness of pooled alendronate and risedronate, compared with strontium ranelate, raloxifene, etidronate and teriparatide. http://wwwniceorguk/pageaspx?o=370643. Accessed 2006/12/12

  34. M Fukunaga K Kushida H Kishimoto M Shiraki Y Taketani H Minaguchi T Inoue R Morita H Morii K Yamamoto Y Ohashi H Orimo (2002) ArticleTitleA comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial Osteoporos Int 13 971–979 Occurrence Handle12459940 Occurrence Handle10.1007/s001980200135 Occurrence Handle1:CAS:528:DC%2BD38XptFGitrY%3D

    Article  PubMed  CAS  Google Scholar 

  35. B Clemmesen P Ravn B Zegels AN Taquet C Christiansen JY Reginster (1997) ArticleTitleA 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis Osteoporos Int 7 488–495 Occurrence Handle9425508 Occurrence Handle10.1007/PL00004152 Occurrence Handle1:STN:280:DyaK1c%2Fos1Kntw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  36. InstitutionalAuthorNameMHLW (2004) Social medical insurance reimbursement survey 2002 (in Japanese) Health and Welfare Statistics Association Tokyo

    Google Scholar 

  37. InstitutionalAuthorNameMHLW (2004) Report of long-term care insurance payment 2002 (in Japanese) Health and Welfare Statistics Association Tokyo

    Google Scholar 

  38. M Rahman M Sekimoto I Takamatsu K Hira T Shimbo K Toyoshima T Fukui (2001) ArticleTitleEconomic evaluation of universal BCG vaccination of Japanese infants Int J Epidemiol 30 380–385 Occurrence Handle11369746 Occurrence Handle10.1093/ije/30.2.380 Occurrence Handle1:STN:280:DC%2BD3M3nsFWksQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  39. MC Weinstein WB Stason (1977) ArticleTitleFoundations of cost-effectiveness analysis for health and medical practices N Engl J Med 296 716–721 Occurrence Handle402576 Occurrence Handle1:STN:280:DyaE2s7itlOhsg%3D%3D Occurrence Handle10.1056/NEJM197703312961304

    Article  PubMed  CAS  Google Scholar 

  40. S Kurimori Y Fukuda K Nakamura M Watanabe T Takano (2006) ArticleTitleCalculation of prefectural disability-adjusted life expectancy (DALE) using long-term care prevalence and its socioeconomic correlates in Japan Health Policy 76 346–358 Occurrence Handle16061303 Occurrence Handle10.1016/j.healthpol.2005.06.017

    Article  PubMed  Google Scholar 

  41. K Yoh K Tanaka A Ishikawa T Ishibashi Y Uchino Y Sato M Tobinaga N Hasegawa S Kamae M Yoshizawa (2005) ArticleTitleHealth-related quality of life (HRQOL) in Japanese osteoporotic patients and its improvement by elcatonin treatment J Bone Miner Metab 23 167–173 Occurrence Handle15750696 Occurrence Handle10.1007/s00774-004-0556-5 Occurrence Handle1:CAS:528:DC%2BD2MXhvF2ru7Y%3D

    Article  PubMed  CAS  Google Scholar 

  42. InstitutionalAuthorNameMHLW (2004) Patient survey 2002 (in Japanese) Health and Welfare Statistics Association Tokyo 430–431

    Google Scholar 

  43. InstitutionalAuthorNameMHLW (2004) Patient survey 2002 (in Japanese) Health and Welfare Statistics Association Tokyo 434–435

    Google Scholar 

  44. CM Klotzbuecher PD Ross PB Landsman TA Abbott SuffixIII M Berger (2000) ArticleTitlePatients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis J Bone Miner Res 15 721–739 Occurrence Handle10780864 Occurrence Handle10.1359/jbmr.2000.15.4.721 Occurrence Handle1:STN:280:DC%2BD3c3ktFOktA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  45. JA Kanis O Johnell A Oden F Borgstrom N Zethraeus C De Laet B Jonsson (2004) ArticleTitleThe risk and burden of vertebral fractures in Sweden Osteoporos Int 15 20–26 Occurrence Handle14593450 Occurrence Handle10.1007/s00198-003-1463-7 Occurrence Handle1:STN:280:DC%2BD2c%2FitlOhsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Health Administration and Policy, Graduate School of Medicine, Tohoku University, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan

    Hansheng Ding, Nobuo Koinuma, Michiya Ito & Yasutake Monma

  2. Aetna School of Management, Shanghai Jiao Tong University, China

    Hansheng Ding

  3. School of Health and Related Research, University of Sheffield, Sheffield, UK

    Matt Stevenson

Authors
  1. Hansheng Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuo Koinuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matt Stevenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michiya Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasutake Monma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hansheng Ding.

About this article

Cite this article

Ding, H., Koinuma, N., Stevenson, M. et al. The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis. J Bone Miner Metab 26, 34–41 (2008). https://doi.org/10.1007/s00774-007-0794-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-007-0794-4

Key words

Search

Navigation